Oluwarotimi Folorunso, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Racemases and Epimerases | 3 | 2021 | 131 | 1.010 |
Why?
|
| Prosencephalon | 1 | 2021 | 317 | 0.710 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 1268 | 0.570 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 4 | 2022 | 920 | 0.450 |
Why?
|
| Mental Health | 1 | 2022 | 2602 | 0.360 |
Why?
|
| Fibroblast Growth Factors | 4 | 2019 | 878 | 0.350 |
Why?
|
| Serine | 2 | 2022 | 852 | 0.340 |
Why?
|
| Alzheimer Disease | 3 | 2022 | 7165 | 0.280 |
Why?
|
| Peptidomimetics | 2 | 2018 | 36 | 0.220 |
Why?
|
| Plaque, Amyloid | 1 | 2022 | 673 | 0.180 |
Why?
|
| Astrocytes | 2 | 2022 | 1229 | 0.170 |
Why?
|
| Pyramidal Cells | 1 | 2020 | 366 | 0.170 |
Why?
|
| Optic Nerve Injuries | 1 | 2019 | 163 | 0.160 |
Why?
|
| Dendrites | 1 | 2020 | 553 | 0.160 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2019 | 421 | 0.160 |
Why?
|
| Molecular Probes | 1 | 2018 | 326 | 0.150 |
Why?
|
| Neuronal Plasticity | 3 | 2022 | 1426 | 0.150 |
Why?
|
| Social Isolation | 1 | 2018 | 332 | 0.140 |
Why?
|
| Amygdala | 1 | 2022 | 1278 | 0.130 |
Why?
|
| Physical Conditioning, Animal | 1 | 2018 | 377 | 0.130 |
Why?
|
| PPAR gamma | 1 | 2017 | 491 | 0.130 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 927 | 0.120 |
Why?
|
| Retinal Diseases | 1 | 2019 | 673 | 0.120 |
Why?
|
| Oligopeptides | 1 | 2018 | 1276 | 0.120 |
Why?
|
| Sodium | 1 | 2018 | 1637 | 0.110 |
Why?
|
| Reperfusion Injury | 1 | 2019 | 1071 | 0.110 |
Why?
|
| Synapses | 1 | 2020 | 1706 | 0.100 |
Why?
|
| Superoxide Dismutase | 1 | 2013 | 607 | 0.100 |
Why?
|
| Brain Injuries | 1 | 2022 | 1909 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 22989 | 0.090 |
Why?
|
| Animals | 11 | 2022 | 170486 | 0.090 |
Why?
|
| HEK293 Cells | 4 | 2019 | 4310 | 0.090 |
Why?
|
| Mice | 8 | 2022 | 80876 | 0.080 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 18375 | 0.080 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2016 | 1345 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2016 | 9774 | 0.080 |
Why?
|
| Mice, Knockout | 5 | 2021 | 15274 | 0.070 |
Why?
|
| Hippocampus | 1 | 2018 | 3639 | 0.070 |
Why?
|
| Synaptic Transmission | 2 | 2022 | 1195 | 0.070 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2022 | 13 | 0.060 |
Why?
|
| Schizophrenia | 1 | 2021 | 6663 | 0.060 |
Why?
|
| Protein Binding | 3 | 2019 | 9639 | 0.050 |
Why?
|
| Sensory Gating | 1 | 2021 | 43 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 12447 | 0.050 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2020 | 115 | 0.050 |
Why?
|
| Leukostasis | 1 | 2019 | 22 | 0.050 |
Why?
|
| Nerve Crush | 1 | 2019 | 86 | 0.050 |
Why?
|
| Neurons | 1 | 2018 | 9385 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2019 | 5456 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2019 | 666 | 0.040 |
Why?
|
| Phosphopeptides | 1 | 2018 | 241 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 13714 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2019 | 8720 | 0.040 |
Why?
|
| Neuroglia | 1 | 2022 | 930 | 0.040 |
Why?
|
| Dentate Gyrus | 1 | 2017 | 164 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 1 | 2018 | 985 | 0.040 |
Why?
|
| Sodium Channels | 1 | 2017 | 376 | 0.030 |
Why?
|
| Social Behavior | 1 | 2021 | 1108 | 0.030 |
Why?
|
| Solubility | 1 | 2016 | 1156 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2019 | 1399 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2018 | 1971 | 0.030 |
Why?
|
| Thiazolidinediones | 1 | 2017 | 484 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2013 | 296 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 9927 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2013 | 12005 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2019 | 1162 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 3209 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2019 | 1200 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 437 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 2018 | 1031 | 0.030 |
Why?
|
| Male | 5 | 2021 | 349524 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 517 | 0.030 |
Why?
|
| Humans | 9 | 2022 | 708843 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2016 | 843 | 0.030 |
Why?
|
| tau Proteins | 1 | 2019 | 1623 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 2673 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2016 | 1461 | 0.020 |
Why?
|
| Axons | 1 | 2017 | 1747 | 0.020 |
Why?
|
| RNA Interference | 1 | 2018 | 3026 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 3645 | 0.020 |
Why?
|
| Autophagy | 1 | 2016 | 1343 | 0.020 |
Why?
|
| Tomography, Optical Coherence | 1 | 2019 | 2483 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 8593 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2021 | 5781 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 11239 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2013 | 1831 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 11790 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2017 | 14215 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2017 | 3866 | 0.020 |
Why?
|
| Age Factors | 1 | 2020 | 18712 | 0.010 |
Why?
|
| Rats | 1 | 2018 | 25094 | 0.010 |
Why?
|
| Proteomics | 1 | 2013 | 3244 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2016 | 20170 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 16959 | 0.010 |
Why?
|
| Female | 3 | 2021 | 375205 | 0.010 |
Why?
|
| Mutation | 1 | 2017 | 29262 | 0.010 |
Why?
|